Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (JPRN-UMIN000059204) titled 'A study to evaluate the safety of long-term consumption of blue rose extract powder' on Sept. 26.
Study Type: Interventional
Study Design:
Single arm Non-randomized
Primary Sponsor: KINJIRUSHI Co., LTD.
Condition:
Healthy Japanese
Intervention:
Duration: 12 weeks Test product: Aurum Blue(R) Rose Ex M (KRE-101) (100 mg/day) Administration: Consume one capsule with water at any time once daily. *If a dose is missed, it should be consumed as soon as remembered. The daily dose should be consumed within the same day and should not be carried over to the following day.
Recruitment Status: Recruiting
Ph...